ArticleHuman vaccines & immunotherapeutics2022

Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study.

Kei Nakashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.